Spur® Peripheral Retrievable Stent System Receives FDA De NovoClearance
We’re proud to announce that our first-of-its-kind Spur Stent System is now commercially available in the U.S. Featuring innovative Spur technology, known as Retrievable Scaffold Therapy (RST), it is intended for the treatment of de novo or restenotic lesions following predilatation in patients with infrapopliteal arterial disease.
Watch the video and read the press release
An Eventful New Cardiovascular Horizons (NCVH) Conference
Thank you to Jay Mathews, MD, MS, FACC, FSCAI, Ashwani Sastry, MD, Michael Siah, MD, and Kevin Herman, MD for sharing their experience and insights at the symposium, “Innovative Tools for Complex BTK (below-the-knee) CLTI (chronic limb-threatening ischemia) disease.” Just one day after the symposium, the FDA granted De Novo clearance for the Spur.
Announcing the New Subsidiary in Germany
Reflow Medical Europe GmbH opened an office in Landsberg am Lech, Germany in January. This expands our international market presence.
Dr. John Rundback Presents DEEPER REVEAL Trial Results at the CX Symposium
An outstanding presentation by John Rundback, MD on April 24th highlighted the potential of Spur RST for treating patients with BTK CLTI.
Challenging the Limits of BTK Intervention at CLI-C Global in Venice, Italy
Marco Manzi, MD successfully utilized the Spur System followed by a DCB in a patient with BTK CLTI during a live case on April 4th. We are grateful to Dr. Manzi and his team at Policlinico Abano Terme (Pd) and chairs Dr. Mariano Palena and Dr. August Ysa.
Teamwork at Asahi General Hospital in Asahi, Japan
We were fortunate to observe several complex lower-limb cases with Naoki Hayakawa, MD, Shinya Ichihara, MD, Yasuyuki Tsuchida, MD and their team using the Reflow Medical Wingman™ CTO Crossing Catheter. It was part of our visit to the Japan Endovascular Treatment Conference (JET) in May.
John Phillips, MD Shares a Compelling Patient Story: The Way to My Heart Podcast
In the June 12th episode with host Kym McNicholas, Dr. Phillips introduces his patient and how he treated his Critical Limb Ischemia (CLI) using the Spur Stent System.
Case Reports Using Spur RST
Three new in-depth case reports detail Spur RST use cases performed by Kevin Herman, MD, Marianne Brodmann, MD and Leyla Schweiger, MD, and Michael Lichtenberg, MD, FESC.
DEEPER LIMUS Trial Final Results
Leyla Schweiger, MD and Marianne Brodmann, MD, both from the Medical University of Graz in Graz, Austria, were the principal investigators for the DEEPER LIMUS trial, and authors of the abstract covering the results of the study. The study evaluated the safety and efficacy of Retrievable Scaffold Therapy combined with sirolimus-coated balloon angioplasty for treating infrapopliteal artery lesions.
Global Reach, Purposeful Growth
An update from Marc Hoewer, Director of Distributor Management, International, Reflow Medical Europe GmbH
“Over the past 12 months, we’ve signed 25 new distribution agreements, expanding our presence to over 50 countries across five continents. Each new partner strengthens our ability to bring life-changing technologies to more patients worldwide. And we’re just getting started.”
Hands-on with Cora Catheters at SCAI
We welcomed visitors to our booth to demo our peripheral and cardiac catheters, including the Cora Catheters line, at the Society for Cardiovascular Angiography & Interventions (SCAI) Scientific Sessions event, held in Washington, DC.
Innovation at LINC
In January, Jay Mathews, MD, MS, FACC, FSCAI shared new data from the DEEPER REVEAL trial and Marcus Thieme, MD reported on the Vessel Recoil Substudy at the Leipzig Interventional Course (LINC). Michael Lichtenberg, MD, FESC moderated the session, “Innovative Approaches in Treating BTK CLTI: How to Cross, Access, and Treat,” with Ashwani Sastry, MD Michael Siah, MD, and Daniel van den Heuvel, MD. An excellent live case involving treatment with Spur RST was shown by Andrej Schmidt, MD and Axel Fischer, MD.
See the post and carousel on LinkedIn
IMENDO Conference—Spur Highlights
We want to thank Andrej Schmidt, MD for his outstanding presentation on Spur RST, and Marianne Brodmann, MD for her talk, “Unmet needs in BTK tools and technologies” highlighting Spur RST at IMENDO, the International Multidisciplinary Endovascular Forum held in February.
Outstanding Symposium: Find Your Algorithm (FYA)
Presentations by Michael Siah, MD of Southwestern Medical Center, and another by our CEO and Co-Founder, Isa Rizk, drew rave reviews at FYA. The next edition of the congress takes place in February 2026.
Leading Experts at the OEIS 2025 Breakfast Symposium
See the post and carousel on LinkedIn
We thank the speakers for their outstanding presentations on Spur RST, Wingman and Spex® at our sponsored symposium at the Outpatient Endovascular and Interventional Society (OEIS) meeting.
Our CEO Shares the Story
Isa Rizk, Co-Founder and CEO of Reflow Medical, spoke at the FYA symposium and attended several conferences this year. He also joined the Life of Flow podcast to talk about building a successful company by following a unique playbook.
Life of Flow Podcast with Reflow Medical’s Abigail Mize
Abigail Mize, a dual-registered cardiac and vascular sonographer, spoke with vascular technologist Jill Sommerset about a game-changing technique for evaluating vascular efficacy.
Q3 ’25 Conference Highlights
